Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,632.19
(
-0.61%
)
US TECH 100
23,737.60
(
-0.64%
)
Dow Jones
46,558.47
(
-0.26%
)
Brent Oil
101.58
(
0.00%
)
Bitcoin
71,436.92
(
0.31%
)
News Focus
News Focus

Replies to post #751527 on NorthWest Biotherapeutics Inc (NWBO)

Replies to #751527 on NorthWest Biotherapeutics Inc (NWBO)
icon url

exwannabe

02/27/25 10:36 AM

#751529 RE: Zadie420 #751527

The problem is We are diluting without knowing where the $ goes. This is not acceptable.



Sawston Business Park, Sawston CB22 3JG, United Kingdom
icon url

dennisdave

02/27/25 11:39 AM

#751550 RE: Zadie420 #751527

The problem is We are diluting without knowing where the $ goes.

the $ raised is to finance Advent a Toucan subisdiary. Not very difficult to grasp
icon url

AAPL31415926

02/27/25 11:47 AM

#751551 RE: Zadie420 #751527

Zadie, Understandably why you are discouraged as I am also somewhat tired, but I've been invested for well over 12 years.
I think you're being somewhat short sighted thinking $3 per share BO. Merck gets $25 billion per year revenue from Keytruda. I think they'd be happy to pay $25B for Nwbo to extend their patent out another 10 years and prevent anyone else from having this treatment. Not to mention all the patents and Flaskworks. And that would probably equal around $15 per share which I think we'd all be happy with.